Christian H. Poehlein, MD
Consultant
Clinical Scientist with over 25 years of experience in Immuno-Oncology (I-O) and Translational Science from bench-to-bedside-to-bench in Academia, Non-Profit and Biotech/Pharma.
15+ years of leadership experience in Biotech/Pharma in Global Clinical Development, Business Development, In-Licensing, Pharma Alliances/Collaborations, Global Medical Affairs.
Specific Therapeutic Area expertise in GU (Prostate, Bladder, RCC), Melanoma I-O, Colorectal Cancer.
Most recently AVP, Late Clinical Development, Asset Lead Opevepostat, Olaparib and Head of Prostate Cancer at Merck&Co. Alliance Lead Olaparib (Astrazeneca), Opevepostat (Orion Pharma), Prostate Cancer Lead Daiichi Sankyo ADC-Portfolio for Merck&Co.
Increasing leadership roles over the past decade in Oncology at Bayer, BMS, Dendreon.
Former faculty member at Earle A. Chiles Research Institute (Adoptive T-cell Therapy, Tumor Vaccine Development).
MD at received at Ludwig-Maximilians-University (LMU) Medical School. PhD in Xenotransplantation at the Surgical Research Institute at LMU.
